Literature DB >> 24251711

Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.

Katsutoshi Tokushige1, Etsuko Hashimoto, Kazuhiko Kodama.   

Abstract

In Japan, there has been a gradual increase in cases of non-viral chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD), occurring with hepatocellular carcinoma (HCC). First, a national survey investigating the etiology of HCC in Japan was performed. Among HCCs based on non-viral disease, alcoholic liver disease with HCC accounted for 7.2% of all HCCs, followed by chronic liver disease of unknown etiology with HCC (5.1%) and NAFLD with HCC (2.0%). The clinical characteristics of these three HCC groups were clearly different. In our second analysis, the HCC development rates among liver cirrhosis with NAFLD, alcoholic cirrhosis, and cirrhosis with hepatitis C virus (HCV) were compared. HCC development rates were 11.3%/5 years in NAFLD cirrhosis, 30.5%/5 years in HCV cirrhosis, and 12.5%/5 years in alcoholic cirrhosis, suggesting that the hepatocarcinogenesis in NAFLD and alcoholic liver disease were similar but were lower than that in HCV. Using Cox hazards analysis, older age, higher serum γ-glutamyl transpeptidase level, and higher Child-Pugh score as risk factors of HCC were identified. Finally, clinical data of NAFLD-HCC with the data for HCC with HCV (HCV-HCC) were compared. The percentage of NAFLD-HCC patients with des-gamma-carboxy prothrombin-positive was higher than that with α-fetoprotein-positive. The 5-year survival and recurrence rates for NAFLD-HCC were almost similar to those for HCV-HCC. In Asian countries, the prevalence of NAFLD is increasing. Therefore, elucidating the pathogenesis and clinical features of HCC in patients with NAFLD is indeed an urgent problem.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  hepatocellular carcinoma (HCC); non-alcoholic fatty liver disease (NAFLD); non-alcoholic steatohepatitis (NASH)

Mesh:

Substances:

Year:  2013        PMID: 24251711     DOI: 10.1111/jgh.12239

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

Review 1.  Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Jun-Ichi Takino; Kentaro Nagamine; Takamitsu Hori; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Hepatol       Date:  2015-10-18

2.  Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.

Authors:  Ping Xu; Cheng-Fu Xu; Xing-Yong Wan; Chao-Hui Yu; Chao Shen; Peng Chen; Gen-Yun Xu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 3.  Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Valerio Nobili; Anna Alisi; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  Gastroenterology       Date:  2016-03-19       Impact factor: 22.682

Review 4.  Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Authors:  Mahmoud A Ali; Sahin Lacin; Reham Abdel-Wahab; Mark Uemura; Manal Hassan; Asif Rashid; Dan G Duda; Ahmed O Kaseb
Journal:  Onco Targets Ther       Date:  2017-03-03       Impact factor: 4.147

Review 5.  Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.

Authors:  Masato Yoneda; Kento Imajo; Hirokazu Takahashi; Yuji Ogawa; Yuichiro Eguchi; Yoshio Sumida; Masashi Yoneda; Miwa Kawanaka; Satoru Saito; Katsutoshi Tokushige; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2017-11-24       Impact factor: 7.527

6.  Stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells.

Authors:  Yasushi Shibasaki; Makoto Horikawa; Koji Ikegami; Ryota Kiuchi; Makoto Takeda; Takanori Hiraide; Yoshifumi Morita; Hiroyuki Konno; Hiroya Takeuchi; Mitsutoshi Setou; Takanori Sakaguchi
Journal:  Cancer Sci       Date:  2018-03-06       Impact factor: 6.716

Review 7.  To die or not to die: death signaling in nonalcoholic fatty liver disease.

Authors:  Yuko Akazawa; Kazuhiko Nakao
Journal:  J Gastroenterol       Date:  2018-03-24       Impact factor: 7.527

Review 8.  The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

Review 9.  Epidemiological differences of common liver conditions between Asia and the West.

Authors:  Thevaraajan Jayaraman; Yeong-Yeh Lee; Wah-Kheong Chan; Sanjiv Mahadeva
Journal:  JGH Open       Date:  2019-10-24

Review 10.  Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link.

Authors:  Lampros Chrysavgis; Ilias Giannakodimos; Panagiota Diamantopoulou; Evangelos Cholongitas
Journal:  World J Gastroenterol       Date:  2022-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.